Rafael Gaiolla

7PUBLICATIONS
37CO-AUTHORS
HaematologyGene and molecular therapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 24, 2025
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil.

Julia Simões Correa Galendi, Hannes Rasch, Carlos Antonio Caramori

|Dec 10, 2024
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.

Vania Hungria, Rafael Gaiolla, Kenny Galvez

|Oct 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry.

Valeria Buccheri, Frederico Rafael Moreira, Irene Biasoli

|Jun 29, 2022
Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol.

Lucas Oliveira Cantadori, Rafael Dezen Gaiolla, Vania Dos Santos Nunes-Nogueira

|Apr 13, 2021
Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.

Maurício Fregonesi Barbosa, Daniéliso Renato Fusco, Rafael Dezen Gaiolla

|Mar 08, 2021
SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.

Rafael Dezen Gaiolla, Marcelo Padovani de Toledo Moraes, Deilson Elgui de Oliveira

Pageof 2

Frequent Collaborators

2 joint publications

Vania Santos Nunes Nogueira

1 joint publications

Maurício Fregonesi Barbosa

1 joint publications

Daniéliso Renato Fusco

1 joint publications

Konrad Werys